UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM SD

 

Specialized Disclosure Report

 

Fresenius Medical Care AG & Co. KGaA

(Exact name of registrant as specified in its charter)

 

 

 

Josef Dinger, +49 6172 608 2522, Josef.Dinger@fmc-ag.com

(Name and telephone number, including area code, of the person to contact in connection with this report.)

 

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

 

x     Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2019.

 

 

 

Introduction

 

Company Overview

 

Fresenius Medical Care AG & Co. KGaA (“FMC-AG & Co. KGaA,” the “Company,” “we,” “us,” or “our”) is the world’s largest kidney dialysis company, based on publicly reported revenue and number of patients treated. We provide dialysis care and related services to persons who suffer from end-stage renal disease (“ESRD”) as well as other health care services. We also develop, manufacture and distribute a wide variety of health care products, which includes dialysis and non-dialysis products. Our dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Our non-dialysis products include acute cardiopulmonary and apheresis products. We supply dialysis clinics we own, operate or manage with a broad range of products and also sell dialysis products to other dialysis service providers. We sell our health care products to customers in around 150 countries and we also use them in our own health care service operations. We describe certain of our other health care services as “Care Coordination.” Care Coordination currently includes, but is not limited to, value and risk-based arrangements, pharmacy services, vascular, cardiovascular and endovascular specialty services as well as ambulatory surgery center services, physician nephrology and cardiology services, urgent care services and ambulant treatment services. All of these Care Coordination services together with dialysis care and related services represent our health care services.

 

Overview of Fresenius’s Conflict Minerals Program

 

In connection with its reporting under Securities and Exchange Commission’s (“SEC”) Rule 13p-1 (the “Conflict Minerals Rule”), the Company designed a program (the “CM Program”) to capture the required data within our supply chain for analysis and disclosure. The CM Program also includes feedback and communication functions to ensure that the CM Program enhances our knowledge of our suppliers to ensure that we are continually evaluating the compatibility of their business practices with our established practices. The CM Program is continuously upgraded to conform, in all material respects, to the Organization for Economic Co-operation and Development (“OECD”) Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas, 3rd Edition and related Supplements on Tin, Tantalum and Tungsten and on Gold (“OECD Guidance”). The OECD Guidance contains the following five-step framework:

 

1.              Establish strong company management systems

2.              Identify and assess risks in our supply chain

3.              Design and implement a strategy to respond to identified risks

4.              Support the development and implementation of independent third-party audits of smelters’ and refiners’ sourcing

5.              Report on supply chain due diligence

 

Conflict Minerals Sourcing Policy

 

Our Conflict Minerals Sourcing Policy (“CM Policy”) governs the sourcing of raw materials, including those materials identified from areas of the world which have been identified as “Covered Countries” (as defined in Item 1.01 below) by the Conflict Minerals Rule. The Company also sources components, or other materials, that may potentially contain an identified Conflict Mineral. Our CM Policy is publicly available at:

 

https://www.freseniusmedicalcare.com/fileadmin/data/com/pdf/About_us/Responsibility/Policy_Conflict_Minerals.pdf

 

Description of Supply Chain

 

We operate production facilities worldwide to meet the demand for our dialysis products and other health care products. We have invested significantly in developing proprietary processes, technologies and manufacturing equipment resulting in a competitive advantage in manufacturing our products. Production facilities and distribution centers are strategically located. This helps to reduce transportation costs and facilitate the distribution of products to our customers.

 

2

 

The Global Manufacturing, Quality & Supply (“GMQS”) division manages the procurement of raw materials and semi-finished goods as well as the manufacturing and distribution of renal products. This center-led approach enables us to:

 

·                  enhance the efficiency of our processes,

 

·                  optimize cost structures,

 

·                  improve returns on our capital invested in manufacturing,

 

·                  respond quickly, and

 

·                  fulfill our commitment to meeting high quality and safety standards.

 

Our procurement policy combines worldwide sourcing of high-quality materials with the establishment of long-term supplier relationships. Additionally, we strive to ensure that purchased materials comply with the quality specifications and safety standards required for our dialysis products. We outsource only after we have qualified suppliers, ensuring they meet our requirements. Interactive Supplier Relationship management and risk management systems connect all our global procurement activities to ensure global transparency, standardized processes and constant monitoring of our projects and supplier-related activities.

 

We focus on further optimizing procurement logistics and reducing total purchasing costs. Corporate frame contracts for the majority of our manufacturers of semi-finished goods and raw materials will enable us to improve purchasing terms for our complete network. We are continuously intensifying, where appropriate, our use of web-based procurement tools to increase agility and global transparency. Our sophisticated routing software enables us to distribute our supplies to best accommodate customer requests while maintaining operational efficiency. Additionally, we have an automated replenishment control in our national warehouses that allows the warehouses to be refilled when their inventory reaches a preset defined minimum level and allows us to continue to improve our operational efficiency.  However, as we are an original equipment manufacturer that assembles and manufactures components and sub-components into finished products, we are largely removed from the processing facilities in our supply chain with regards to conflict minerals and we must rely on the information provided by our suppliers through various due diligence processes.

 

Section 1 - Conflict Minerals Disclosure

 

Item 1.01 Conflict Minerals Disclosure and Report, Exhibit

 

Reasonable Country of Origin Inquiry Conclusion:

 

The Company performed due diligence to determine the source and chain of custody of the conflict minerals necessary to the production or functionality of certain of its products. However, for 2019, the Company determined, in good faith, that it was unable to definitively ascertain whether the conflict minerals, necessary for the functionality or production of the relevant products manufactured or contracted to manufacture by the Company, financed or benefitted armed groups in the Democratic Republic of the Congo (“DRC”) or in the countries having an internationally recognized border with the DRC, including Angola, Burundi, Central African Republic, Republic of the Congo, Rwanda, South Sudan, Tanzania, Uganda, and Zambia (together the “Covered Countries”).

 

Description of Reasonable Country of Origin Inquiry

 

Our Reasonable Country of Origin Inquiry (“RCOI”) was conducted, in good faith, through the collection of conflict minerals data from suppliers that we determined to be at-risk for potentially containing the identified minerals in the products that they provided to us during 2019. These products are enumerated in the Conflict Minerals Report filed as Exhibit 1.01 to this Form SD. Moreover, our RCOI was developed based upon industry best practices in collaboration with a third-party consultant (iPoint, Inc.).

 

3

 

Our RCOI conflict minerals data collection process includes, but is not limited to, the following:

 

1.              Develop and distribute free, educational material and training to relevant suppliers

2.              Initiate survey campaign from relevant suppliers utilizing the cross-industry Conflict Minerals Reporting Template (“CMRT”), developed by the Responsible Minerals Initiative (“RMI”), as well as the iPoint Conflict Minerals Platform (“iPCMP”)

3.              Compare conflict minerals data received from relevant suppliers to Country of Origin (“CoO”) information available to us via our membership to the RMI

 

A copy of our Conflict Minerals Report is filed as Exhibit 1.01 hereto and is publicly available at https://www.freseniusmedicalcare.com/en/about-us/sustainability/supply-chain/.

 

Item 1.02 Exhibits

 

Section 2 — Exhibits

 

Item 2.01 Exhibits

 

The following exhibit is filed as part of this report.

 

Exhibit 1.01 — Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

 

FRESENIUS MEDICAL CARE AG & CO. KGaA, a partnership
limited by shares, represented by:
FRESENIUS MEDICAL CARE MANAGEMENT AG,
its general partner
By:	/s/ Helen Giza
Name:	Helen Giza
Title	Chief Financial Officer and
	Member of the Management Board
	of the General Partner
	Date: May 29, 2020
By:	/s/ Kent Wanzek
Name:	Kent Wanzek
Title	Chief Executive Officer of Global Manufacturing
	Quality & Supply and
	Member of the Management Board
	of the General Partner
	Date: May 29, 2020

 

4

Exhibit 1.01

 

Fresenius Medical Care AG & Co. KGaA

 

Conflict Minerals Report

 

This document, constituting Exhibit 1.01 to Form SD of Fresenius Medical Care AG & Co. KGaA (together with its subsidiaries, “Fresenius Medical Care,” “the Company,” “we,” “our”), for calendar year 2019, is the Company’s Conflict Minerals Report in accordance with Rule 13p-1 under the Securities Exchange Act of 1934. As the Company has shares listed on the New York Stock Exchange, it is subject to the provisions of Section 1502 of the U.S. Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank Act”) relating to “Conflict Minerals.” Section 1502 of the Dodd-Frank Act and Rule 13p-1 of the Securities Exchange Commission (“SEC”) address the sourcing of tin, tantalum, tungsten, and gold (“3TG minerals”) from the Democratic Republic of the Congo (“DRC”) and adjoining countries (“Covered Countries”) which are known locations where armed groups mine and sell these minerals to finance civil violence.

 

The following is a description of the measures taken by the Company, a registrant, to exercise due diligence on the source and chain of custody of the subject minerals.

 

Section (1) Due Diligence:

 

The Company’s comprehensive Conflict Minerals Program (“CM Program”) includes a due diligence process that was designed to conform, in all material respects, to the criteria set forth in the internationally recognized Organization for Economic Co-operation and Development (“OECD”) Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas, 3rd Edition and related Supplements on Tin, Tantalum and Tungsten and on Gold (“OECD Guidance”).

 

The following is a review of the actions comprising the OECD Guidance five-step framework that the Company took to implement our due diligence process:

 

1.              Establish strong company management systems

 

a.         The Company developed and adopted a Conflict Minerals Sourcing Policy and made it publicly available at https://www.freseniusmedicalcare.com/fileadmin/data/com/pdf/About_us/Responsibility/Policy_Conflict_Minerals.pdf

 

b.         The Company structured internal management to support supply chain due diligence by identifying the responsible business organizations and the individuals within those organizations and establishing a cross-functional Conflict Minerals team (“the Team”). The primary and secondary contributors on the Team were designated and notified of their responsibilities. As part of the Company’s annual program review process, the Team conducted an on-site workshop to identify areas for improvement and provide internal training to relevant personnel.

 

c.          The Company established a system of controls over the supply chain by leveraging the iPoint Conflict Minerals Platform (“iPCMP”) developed by our consultant, iPoint, Inc., to monitor all relevant data.

 

d.         The Company continued to strengthen and improve supplier engagement over previous years by refining the free training made available to suppliers. The Company also provided feedback and engagement recommendations to suppliers that declared potential smelters or refiners in their supply chains.

 

e.          The Company maintains a grievance mechanism in the form of an email inbox, available to the public at cminquiry@fmc-ag.com, also accessible via https://www.freseniusmedicalcare.com/en/about-us/sustainability/supply-chain/.

 

2.              Identify and assess risk in the supply chain

 

a.         The Company identified risk in the supply chain by first identifying each relevant manufacturing facility, globally. A Subject Matter Expert (“SME”) was identified for each facility to be the primary internal personnel with the highest degree of familiarity with the materials, products, and processes for each corresponding facility.  In collaboration with the SMEs, the Team then identified the relevant materials that may contain conflict minerals, reviewed the Company’s

 

 

product portfolio and identified the products that may contain the previously identified materials. As a result, products manufactured or contracted to manufacture with the potential for being at-risk of containing conflict minerals were identified. After identification of the potentially at-risk products, the SMEs referenced their own supplier and/or procurement data, in addition to their existing expertise with that specific supply chain, and were able to determine the applicable suppliers with whom the Reasonable Country of Origin Inquiry (“RCOI”) and corresponding due diligence were to be conducted.

 

b.         The addition of the SMEs knowledge and expertise into the risk identification process enabled the Company to focus its resources on suppliers that represented the highest risk of potentially containing conflict minerals in the products that we purchased during the relevant time period.

 

c.          Following the initial identification of potentially at-risk suppliers, the Company began its RCOI process.

 

d.         For a supplier to be considered at-risk during the RCOI process, they were either non-compliant or provided smelter data that indicated potential risk. At-risk suppliers were then escalated to the Team for further review and due diligence on an individual supplier basis. The Company’s method for identifying risk of potential financing or benefitting of armed groups is an evolving and ongoing process.

 

3.              Design and implement a strategy to respond to risks

 

a.         The Team communicates with senior leadership, on a yearly basis, any material risk that may be in the supply chain, in addition to ad-hoc meetings to review program progress.

 

b.         The Company devised and implemented a 3-step risk-management strategy:

 

i.                  A review of the returned RCOI data from the relevant suppliers was performed.

 

ii.               Due diligence was conducted with the corresponding supplier(s), if necessary.

 

iii.            An evaluation of the supplier for compliance was conducted.  In order to be considered non-compliant, a supplier was either unresponsive, non-compliant with our policy or did not meet our expectations.

 

c.          As part of the strategy to respond to risk, the Team provided educational risk management training that included the escalation process as a topic to the relevant personnel.

 

d.         The Team was able to identify, monitor and track performance of their risk mitigation efforts and include that information in the meetings with senior leadership utilizing iPCMP for identification, monitoring and tracking of performance.

 

e.          Risk mitigation processes remain in place and are communicated to both the relevant Company personnel, as well as suppliers. As a member of the Responsible Minerals Initiative (“RMI”), our risk mitigation processes related to facilities that smelt, refine and/or process the subject raw materials also remain in place and are consistently reviewed, as demonstrated by the Responsible Minerals Assurance Process (“RMAP”).

 

4.              Support the development and implementation of independent third-party audits of smelters’ and refiners’ sourcing

 

a.         The Company is a member of the RMI, which conducts independent third-party audits of smelters on behalf of its members. The Company utilizes the RCOI information provided to members of the RMI to determine the possible country of origin of the conflict minerals necessary for the functionality or production of its products.

 

5.              Report on supply chain due diligence

 

a.         The Company reports annually to the SEC on Form SD.

 

b.         The Company makes its Conflict Minerals Report publicly available on the SEC web site and at https://www.freseniusmedicalcare.com/en/about-us/sustainability/supply-chain/.

 

Steps taken and being taken to mitigate risk:

 

The Company has taken a number of steps to (i) mitigate the risk that its necessary conflict minerals benefit armed groups in the DRC and/or Covered Countries and (ii) to improve its due diligence. Those steps include:

 

·                  Continuing to provide educational training to our suppliers and the relevant personnel at the Company

·                  Improving our initial risk identification methodology as discussed in Section (1) Due Diligence (1-4)

·                  Focus of resources on risk-based due diligence, as discussed in the OECD Due Diligence Guidance

 

 

The content of any website referred to in this Report is included for general information only and is not incorporated by reference to this Report.

 

(1) Product Description:

 

The Company has determined, in good faith, that the applicable product categories are the following:

 

·                  Dialysis products

·                  Non-dialysis products

 

The Conflict Minerals Rule requires a Conflict Minerals Report to include description of a registrant’s products that have not been found to be “DRC conflict free.”  However, under the guidance referred to under “(2), Product Determination” below, we are not required to describe any of our products as having “not been found to be DRC Conflict Free.  Accordingly, we have not included a description of our products in this Conflict Minerals Report.  Information regarding our dialysis and non-dialysis products may be found in “Item 4. Information on the Company — B. Business overview — Dialysis Products” at pages 24 - 27 of our Annual Report on Form 20-F for the year ended December 31, 2019. This reference to our Form 20-F is included for general information only and our Form 20-F is not incorporated by reference to this Report.

 

(2) Product Determination:

 

Pursuant to guidance issued by the SEC Division of Corporation Finance on April 29, 2014, we are not required to describe any of our products as “DRC Conflict Free,” as having “not been found to be ‘DRC Conflict Free’” or as “DRC Conflict Undeterminable.” In addition, inasmuch as we have not voluntarily elected to describe any of our products as DRC conflict free, the requirement for an independent private sector audit of this report is not applicable.

 

Results of our RCOI and Due Diligence Measures:

 

Table 1 reflects the result of our RCOI and due diligence. The countries listed in the table are potential sources of origin of the conflict minerals necessary for the functionality or manufacture of the products identified above in “Product Description,” according to the country of origin information available to us as RMI members.

 

The smelters and refiners as defined by the SEC Final Ruling section II(A)(3) declared by our supply chain can be found in Table 2.

 

Table 1

 

Gold		Tantalum		Tin		Tungsten
Argentina		Australia		Australia		Australia
Benin		Austria		Bolivia (Plurinational State of)		Austria
Bolivia (Plurinational State of)		Bolivia (Plurinational State of)		Brazil		Bolivia
Brazil		Brazil		Burundi		Brazil
Canada		Burundi		China		Burundi
Chile		China		Colombia		China
Colombia		Colombia		Congo, Democratic Republic of the		Colombia
Ecuador		Congo, Democratic Republic of the		Guinea		Congo, Democratic Republic of the
Eritrea		Ethiopia		Indonesia		Guinea

 

 

Ghana		France		Laos		Indonesia
Guinea		Germany		Malaysia		Laos
Guyana		Guinea		Mongolia		Malaysia
Japan		India		Myanmar		Mongolia
Mali		Madagascar		Nigeria		Myanmar
Mauritania		Malaysia		Peru		Nigeria
Mexico		Mozambique		Portugal		Peru
Nicaragua		Namibia		Russian Federation		Portugal
Niger		Nigeria		Rwanda		Russian Federation
Peru		Russian Federation		Taiwan		Rwanda
Russian Federation		Rwanda		Thailand		Spain
Rwanda		Sierra Leone		Uganda		Taiwan
South Africa		Somaliland		United Kingdom of Great Britain and Northern Ireland		Thailand
Swaziland		Spain		Venezuela		Uganda
Tanzania		Thailand		Vietnam		United Kingdom of Great Britain and Northern Ireland
Togo		Zimbabwe				United States of America
Uganda						Uzbekistan
United States of America						Vietnam

 

 

Table 2

 

Name		Metal		Smelter ID
8853 S.p.A.		Gold		CID002763
Advanced Chemical Company		Gold		CID000015
Aida Chemical Industries Co., Ltd.		Gold		CID000019
Al Etihad Gold Refinery DMCC		Gold		CID002560
Allgemeine Gold-und Silberscheideanstalt A.G.		Gold		CID000035
Almalyk Mining and Metallurgical Complex (AMMC)		Gold		CID000041
AngloGold Ashanti Corrego do Sitio Mineracao		Gold		CID000058
Argor-Heraeus S.A.		Gold		CID000077
Asahi Pretec Corp.		Gold		CID000082
Asahi Refining Canada Ltd.		Gold		CID000924
Asahi Refining USA Inc.		Gold		CID000920
Asaka Riken Co., Ltd.		Gold		CID000090
AU Traders and Refiners		Gold		CID002850
Aurubis AG		Gold		CID000113
Bangalore Refinery		Gold		CID002863
Bangko Sentral ng Pilipinas (Central Bank of the Philippines)		Gold		CID000128
Boliden AB		Gold		CID000157
C. Hafner GmbH + Co. KG		Gold		CID000176
CCR Refinery - Glencore Canada Corporation		Gold		CID000185
Cendres + Metaux S.A.		Gold		CID000189
Chimet S.p.A.		Gold		CID000233
Chugai Mining		Gold		CID000264
DODUCO GmbH		Gold		CID000362
Dowa		Gold		CID000401
DS PRETECH Co., Ltd.		Gold		CID003195
DSC (Do Sung Corporation)		Gold		CID000359
Eco-System Recycling Co., Ltd. East Plant		Gold		CID000425
Eco-System Recycling Co., Ltd. North Plant		Gold		CID003424
Eco-System Recycling Co., Ltd. West Plant		Gold		CID003425
Emirates Gold DMCC		Gold		CID002561
Geib Refining Corporation		Gold		CID002459
Gold Refinery of Zijin Mining Group Co., Ltd.		Gold		CID002243
Heimerle + Meule GmbH		Gold		CID000694
Heraeus Metals Hong Kong Ltd.		Gold		CID000707
Heraeus Precious Metals GmbH & Co. KG		Gold		CID000711
Inner Mongolia Qiankun Gold and Silver Refinery Share Co., Ltd.		Gold		CID000801
Ishifuku Metal Industry Co., Ltd.		Gold		CID000807
Istanbul Gold Refinery		Gold		CID000814
Italpreziosi		Gold		CID002765

 

 

Japan Mint		Gold		CID000823
Jiangxi Copper Co., Ltd.		Gold		CID000855
JSC Uralelectromed		Gold		CID000929
JX Nippon Mining & Metals Co., Ltd.		Gold		CID000937
Kazzinc		Gold		CID000957
Kennecott Utah Copper LLC		Gold		CID000969
KGHM Polska Miedz Spolka Akcyjna		Gold		CID002511
Kojima Chemicals Co., Ltd.		Gold		CID000981
Korea Zinc Co., Ltd.		Gold		CID002605
Kyrgyzaltyn JSC		Gold		CID001029
L’Orfebre S.A.		Gold		CID002762
LS-NIKKO Copper Inc.		Gold		CID001078
LT Metal Ltd.		Gold		CID000689
Marsam Metals		Gold		CID002606
Materion		Gold		CID001113
Matsuda Sangyo Co., Ltd.		Gold		CID001119
Metalor Technologies (Hong Kong) Ltd.		Gold		CID001149
Metalor Technologies (Singapore) Pte., Ltd.		Gold		CID001152
Metalor Technologies (Suzhou) Ltd.		Gold		CID001147
Metalor Technologies S.A.		Gold		CID001153
Metalor USA Refining Corporation		Gold		CID001157
Metalurgica Met-Mex Penoles S.A. De C.V.		Gold		CID001161
Mitsubishi Materials Corporation		Gold		CID001188
Mitsui Mining and Smelting Co., Ltd.		Gold		CID001193
MMTC-PAMP India Pvt., Ltd.		Gold		CID002509
Moscow Special Alloys Processing Plant		Gold		CID001204
Nadir Metal Rafineri San. Ve Tic. A.S.		Gold		CID001220
Nihon Material Co., Ltd.		Gold		CID001259
Ogussa Osterreichische Gold- und Silber-Scheideanstalt GmbH		Gold		CID002779
Ohura Precious Metal Industry Co., Ltd.		Gold		CID001325
OJSC “The Gulidov Krasnoyarsk Non-Ferrous Metals Plant” (OJSC Krastsvetmet)		Gold		CID001326
OJSC Novosibirsk Refinery		Gold		CID000493
PAMP S.A.		Gold		CID001352
Planta Recuperadora de Metales SpA		Gold		CID002919
Prioksky Plant of Non-Ferrous Metals		Gold		CID001386
PT Aneka Tambang (Persero) Tbk		Gold		CID001397
PX Precinox S.A.		Gold		CID001498
Rand Refinery (Pty) Ltd.		Gold		CID001512
REMONDIS PMR B.V.		Gold		CID002582
Royal Canadian Mint		Gold		CID001534
SAAMP		Gold		CID002761

 

 

Safimet S.p.A		Gold		CID002973
Samduck Precious Metals		Gold		CID001555
SAXONIA Edelmetalle GmbH		Gold		CID002777
SEMPSA Joyeria Plateria S.A.		Gold		CID001585
Shandong Zhaojin Gold & Silver Refinery Co., Ltd.		Gold		CID001622
Sichuan Tianze Precious Metals Co., Ltd.		Gold		CID001736
Singway Technology Co., Ltd.		Gold		CID002516
SOE Shyolkovsky Factory of Secondary Precious Metals		Gold		CID001756
Solar Applied Materials Technology Corp.		Gold		CID001761
Sumitomo Metal Mining Co., Ltd.		Gold		CID001798
SungEel HiMetal Co., Ltd.		Gold		CID002918
T.C.A S.p.A		Gold		CID002580
Tanaka Kikinzoku Kogyo K.K.		Gold		CID001875
The Refinery of Shandong Gold Mining Co., Ltd.		Gold		CID001916
Tokuriki Honten Co., Ltd.		Gold		CID001938
TOO Tau-Ken-Altyn		Gold		CID002615
Torecom		Gold		CID001955
Umicore Brasil Ltda.		Gold		CID001977
Umicore Precious Metals Thailand		Gold		CID002314
Umicore S.A. Business Unit Precious Metals Refining		Gold		CID001980
United Precious Metal Refining, Inc.		Gold		CID001993
Valcambi S.A.		Gold		CID002003
Western Australian Mint (T/a The Perth Mint)		Gold		CID002030
WIELAND Edelmetalle GmbH		Gold		CID002778
Yamakin Co., Ltd.		Gold		CID002100
Yokohama Metal Co., Ltd.		Gold		CID002129
Zhongyuan Gold Smelter of Zhongjin Gold Corporation		Gold		CID002224
Asaka Riken Co., Ltd.		Tantalum		CID000092
Changsha South Tantalum Niobium Co., Ltd.		Tantalum		CID000211
Guangdong Rising Rare Metals-EO Materials Ltd.		Tantalum		CID000291
Exotech Inc.		Tantalum		CID000456
F & X Electro-Materials Ltd.		Tantalum		CID000460
Guangdong Zhiyuan New Material Co., Ltd.		Tantalum		CID000616
JiuJiang JinXin Nonferrous Metals Co., Ltd.		Tantalum		CID000914
Jiujiang Tanbre Co., Ltd.		Tantalum		CID000917
LSM Brasil S.A.		Tantalum		CID001076
Metallurgical Products India Pvt., Ltd.		Tantalum		CID001163
Mineracao Taboca S.A.		Tantalum		CID001175
Mitsui Mining and Smelting Co., Ltd.		Tantalum		CID001192
NPM Silmet AS		Tantalum		CID001200
Ningxia Orient Tantalum Industry Co., Ltd.		Tantalum		CID001277

 

 

QuantumClean		Tantalum		CID001508
Yanling Jincheng Tantalum & Niobium Co., Ltd.		Tantalum		CID001522
Solikamsk Magnesium Works OAO		Tantalum		CID001769
Taki Chemical Co., Ltd.		Tantalum		CID001869
Telex Metals		Tantalum		CID001891
Ulba Metallurgical Plant JSC		Tantalum		CID001969
Hengyang King Xing Lifeng New Materials Co., Ltd.		Tantalum		CID002492
D Block Metals, LLC		Tantalum		CID002504
FIR Metals & Resource Ltd.		Tantalum		CID002505
Jiujiang Zhongao Tantalum & Niobium Co., Ltd.		Tantalum		CID002506
XinXing Haorong Electronic Material Co., Ltd.		Tantalum		CID002508
Jiangxi Dinghai Tantalum & Niobium Co., Ltd.		Tantalum		CID002512
KEMET Blue Metals		Tantalum		CID002539
H.C. Starck Co., Ltd.		Tantalum		CID002544
H.C. Starck Tantalum and Niobium GmbH		Tantalum		CID002545
H.C. Starck Hermsdorf GmbH		Tantalum		CID002547
H.C. Starck Inc.		Tantalum		CID002548
H.C. Starck Ltd.		Tantalum		CID002549
H.C. Starck Smelting GmbH & Co. KG		Tantalum		CID002550
Global Advanced Metals Boyertown		Tantalum		CID002557
Global Advanced Metals Aizu		Tantalum		CID002558
KEMET Blue Powder		Tantalum		CID002568
Resind Industria e Comercio Ltda.		Tantalum		CID002707
Jiangxi Tuohong New Raw Material		Tantalum		CID002842
PRG Dooel		Tantalum		CID002847
Jiujiang Janny New Material Co., Ltd.		Tantalum		CID003191
Chenzhou Yunxiang Mining and Metallurgy Co., Ltd.		Tin		CID000228
Alpha		Tin		CID000292
CV Gita Pesona		Tin		CID000306
PT Aries Kencana Sejahtera		Tin		CID000309
PT Premium Tin		Tin		CID000313
CV United Smelting		Tin		CID000315
Dowa		Tin		CID000402
EM Vinto		Tin		CID000438
Fenix Metals		Tin		CID000468
Gejiu Non-Ferrous Metal Processing Co., Ltd.		Tin		CID000538
Gejiu Zili Mining And Metallurgy Co., Ltd.		Tin		CID000555
Huichang Jinshunda Tin Co., Ltd.		Tin		CID000760
Gejiu Kai Meng Industry and Trade LLC		Tin		CID000942
China Tin Group Co., Ltd.		Tin		CID001070
Malaysia Smelting Corporation (MSC)		Tin		CID001105

 

 

Metallic Resources, Inc.		Tin		CID001142
Mineracao Taboca S.A.		Tin		CID001173
Minsur		Tin		CID001182
Mitsubishi Materials Corporation		Tin		CID001191
Jiangxi New Nanshan Technology Ltd.		Tin		CID001231
O.M. Manufacturing (Thailand) Co., Ltd.		Tin		CID001314
Operaciones Metalurgical S.A.		Tin		CID001337
PT Artha Cipta Langgeng		Tin		CID001399
PT Babel Inti Perkasa		Tin		CID001402
PT Babel Surya Alam Lestari		Tin		CID001406
PT Bangka Tin Industry		Tin		CID001419
PT Belitung Industri Sejahtera		Tin		CID001421
PT Bukit Timah		Tin		CID001428
PT DS Jaya Abadi		Tin		CID001434
PT Karimun Mining		Tin		CID001448
PT Mitra Stania Prima		Tin		CID001453
PT Panca Mega Persada		Tin		CID001457
PT Prima Timah Utama		Tin		CID001458
PT Refined Bangka Tin		Tin		CID001460
PT Sariwiguna Binasentosa		Tin		CID001463
PT Stanindo Inti Perkasa		Tin		CID001468
PT Sumber Jaya Indah		Tin		CID001471
PT Timah Tbk Kundur		Tin		CID001477
PT Timah Tbk Mentok		Tin		CID001482
PT Tinindo Inter Nusa		Tin		CID001490
PT Tommy Utama		Tin		CID001493
Rui Da Hung		Tin		CID001539
Soft Metais Ltda.		Tin		CID001758
Thaisarco		Tin		CID001898
Gejiu Yunxin Nonferrous Electrolysis Co., Ltd.		Tin		CID001908
White Solder Metalurgia e Mineracao Ltda.		Tin		CID002036
Yunnan Chengfeng Non-ferrous Metals Co., Ltd.		Tin		CID002158
Yunnan Tin Company Limited		Tin		CID002180
CV Venus Inti Perkasa		Tin		CID002455
Magnu’s Minerais Metais e Ligas Ltda.		Tin		CID002468
PT Tirus Putra Mandiri		Tin		CID002478
Melt Metais e Ligas S.A.		Tin		CID002500
PT ATD Makmur Mandiri Jaya		Tin		CID002503
O.M. Manufacturing Philippines, Inc.		Tin		CID002517
PT Inti Stania Prima		Tin		CID002530
CV Ayi Jaya		Tin		CID002570

 

 

CV Dua Sekawan		Tin		CID002592
PT Rajehan Ariq		Tin		CID002593
Resind Industria e Comercio Ltda.		Tin		CID002706
Metallo Belgium N.V.		Tin		CID002773
Metallo Spain S.L.U.		Tin		CID002774
PT Bangka Prima Tin		Tin		CID002776
PT Sukses Inti Makmur		Tin		CID002816
PT Kijang Jaya Mandiri		Tin		CID002829
Thai Nguyen Mining and Metallurgy Co., Ltd.		Tin		CID002834
PT Menara Cipta Mulia		Tin		CID002835
HuiChang Hill Tin Industry Co., Ltd.		Tin		CID002844
Gejiu Fengming Metallurgy Chemical Plant		Tin		CID002848
Guanyang Guida Nonferrous Metal Smelting Plant		Tin		CID002849
PT Lautan Harmonis Sejahtera		Tin		CID002870
Guangdong Hanhe Non-Ferrous Metal Co., Ltd.		Tin		CID003116
Chifeng Dajingzi Tin Industry Co., Ltd.		Tin		CID003190
PT Bangka Serumpun		Tin		CID003205
Tin Technology & Refining		Tin		CID003325
Ma’anshan Weitai Tin Co., Ltd.		Tin		CID003379
PT Rajawali Rimba Perkasa		Tin		CID003381
Luna Smelter, Ltd.		Tin		CID003387
Yunnan Yunfan Non-ferrous Metals Co., Ltd.		Tin		CID003397
A.L.M.T. TUNGSTEN Corp.		Tungsten		CID000004
Kennametal Huntsville		Tungsten		CID000105
Guangdong Xianglu Tungsten Co., Ltd.		Tungsten		CID000218
Chongyi Zhangyuan Tungsten Co., Ltd.		Tungsten		CID000258
Fujian Jinxin Tungsten Co., Ltd.		Tungsten		CID000499
Global Tungsten & Powders Corp.		Tungsten		CID000568
Hunan Chenzhou Mining Co., Ltd.		Tungsten		CID000766
Hunan Chunchang Nonferrous Metals Co., Ltd.		Tungsten		CID000769
Japan New Metals Co., Ltd.		Tungsten		CID000825
Ganzhou Huaxing Tungsten Products Co., Ltd.		Tungsten		CID000875
Kennametal Fallon		Tungsten		CID000966
Tejing (Vietnam) Tungsten Co., Ltd.		Tungsten		CID001889
Wolfram Bergbau und Hutten AG		Tungsten		CID002044
Xiamen Tungsten Co., Ltd.		Tungsten		CID002082
Xinhai Rendan Shaoguan Tungsten Co., Ltd.		Tungsten		CID002095
Ganzhou Jiangwu Ferrotungsten Co., Ltd.		Tungsten		CID002315
Jiangxi Yaosheng Tungsten Co., Ltd.		Tungsten		CID002316
Jiangxi Xinsheng Tungsten Industry Co., Ltd.		Tungsten		CID002317
Jiangxi Tonggu Non-ferrous Metallurgical & Chemical Co., Ltd.		Tungsten		CID002318

 

 

Malipo Haiyu Tungsten Co., Ltd.		Tungsten		CID002319
Xiamen Tungsten (H.C.) Co., Ltd.		Tungsten		CID002320
Jiangxi Gan Bei Tungsten Co., Ltd.		Tungsten		CID002321
Ganzhou Seadragon W & Mo Co., Ltd.		Tungsten		CID002494
Asia Tungsten Products Vietnam Ltd.		Tungsten		CID002502
Chenzhou Diamond Tungsten Products Co., Ltd.		Tungsten		CID002513
H.C. Starck Tungsten GmbH		Tungsten		CID002541
H.C. Starck Smelting GmbH & Co. KG		Tungsten		CID002542
Masan Tungsten Chemical LLC (MTC)		Tungsten		CID002543
Jiangwu H.C. Starck Tungsten Products Co., Ltd.		Tungsten		CID002551
Hunan Chuangda Vanadium Tungsten Co., Ltd. Wuji		Tungsten		CID002579
Niagara Refining LLC		Tungsten		CID002589
Ganzhou Haichuang Tungsten Co., Ltd.		Tungsten		CID002645
Hydrometallurg, JSC		Tungsten		CID002649
Unecha Refractory Metals Plant		Tungsten		CID002724
South-East Nonferrous Metal Company Limited of Hengyang City		Tungsten		CID002815
Philippine Chuangxin Industrial Co., Inc.		Tungsten		CID002827
Xinfeng Huarui Tungsten & Molybdenum New Material Co., Ltd.		Tungsten		CID002830
ACL Metais Eireli		Tungsten		CID002833
Woltech Korea Co., Ltd.		Tungsten		CID002843
Moliren Ltd.		Tungsten		CID002845
Hunan Litian Tungsten Industry Co., Ltd.		Tungsten		CID003182
KGETS Co., Ltd.		Tungsten		CID003388
Fujian Ganmin RareMetal Co., Ltd.		Tungsten		CID003401
Lianyou Metals Co., Ltd.		Tungsten		CID003407